MAPK8 and esophageal squamous cell carcinoma: Mechanistically, anisomycin, a JNK signaling pathway activator, effectively reversed SNORA58‐mediated suppression of the JNK signaling pathway, thereby increasing cellular ferroptosis levels and restoring the radiosensitivity of ESCC cells.